{"entity":{"id":"jean-philippe-spano","kind":"person","name":"Jean-Philippe Spano","aka":[],"tldr":"Jean-Philippe Spano represents Institut Universitaire de Cancérologie AP-HP Sorbonne Université in the Organisation of European Cancer Institutes, which lists the centre among its members in France.","summary":"Jean-Philippe Spano is listed by the Organisation of European Cancer Institutes (OECI) as the representative of Institut Universitaire de Cancérologie AP-HP Sorbonne Université, its member in France. The university cancer institute of AP-HP and Sorbonne Université, spanning the Pitié-Salpêtrière, Saint-Antoine and Tenon hospitals, and accredited by OECI as a Comprehensive Cancer Centre. OnCo records the name from the OECI membership list so that the centre's page has a named contact point; the person's exact title, appointment date and biography are not yet recorded and should be checked on the institution's own pages before being relied on.","asOf":"2026-09-10","links":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Institut Universitaire de Cancérologie AP-HP Sorbonne Université website","url":"https://iuc-aphp-sorbonneuniversite.com/"}],"tags":["oeci-representative","leader"],"related":["oeci"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["iuc-aphp-sorbonne"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Representative of Institut Universitaire de Cancérologie AP-HP Sorbonne Université to the Organisation of European Cancer Institutes","institutionId":"iuc-aphp-sorbonne","specialisms":["Cancer centre representation (OECI)"],"profiles":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Institut Universitaire de Cancérologie AP-HP Sorbonne Université website","url":"https://iuc-aphp-sorbonneuniversite.com/"}],"papers":[{"title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","journal":"Lancet Oncol","year":2018,"url":"https://doi.org/10.1016/s1470-2045(18)30608-9","doi":"10.1016/s1470-2045(18)30608-9","note":"Europe PMC author record matched by affiliation"},{"title":"Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study","journal":"Lancet","year":2008,"url":"https://doi.org/10.1016/s0140-6736(08)60661-3","doi":"10.1016/s0140-6736(08)60661-3","note":"Europe PMC author record matched by affiliation"},{"title":"Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes","journal":"Oncotarget","year":2014,"url":"https://doi.org/10.18632/oncotarget.2454","doi":"10.18632/oncotarget.2454","note":"Europe PMC author record matched by affiliation"}],"orcid":"0000-0002-3921-2479"},"route":"/people/jean-philippe-spano/","neighbours":{"institution":[{"id":"iuc-aphp-sorbonne","kind":"institution","name":"Institut Universitaire de Cancérologie AP-HP Sorbonne Université","route":"/institutions/iuc-aphp-sorbonne/"},{"id":"oeci","kind":"institution","name":"Organisation of European Cancer Institutes","route":"/institutions/oeci/"}]}}